MOA of Tetracycline Antibiotics

MOA of Tetracycline Antibiotics

Tetracycline Antibiotics

Discovered in the late 1940s, tetracyclines are a family of broad-spectrum antibiotics used to treat a wide range of bacterial infections. The original tetracyclines were derived from Streptomyces bacteria, but the newer derivatives are semi-synthetic.

Some representative tetracyclines include:

·              tetracycline

·             doxycycline

·             minocycline

·             panmycin

·             terramycin

·             trimocycline

Tetracycline Mode of Action

Tetracyclines exert their bacteriostatic effect by inhibiting protein synthesis in bacteria.

This antibiotic prevents transfer-RNA (tRNA) molecules (a type of nucleic acids which

transport amino acids) from binding to the 30S subunit of bacterial ribosomes.

It is possible for tetracyclines to inhibit protein synthesis in the eukaryotic cells of the host, but the drug is less likely to reach the required concentrations in humans because eukaryotic cells do not have a tetracycline uptake mechanism.

Antimicrobial Spectrum of Tetracyclines

Tetracyclines are broad-spectrum antibiotics which exhibit activity against a wide range of microbes including both Gram-positive (Gram+) and Gram-negative

(Gram-) bacteria, chlamydias, mycoplasmas, rickettsiae, as well as some protozoan parasites.

Type of Infections Tetracyclines Are Used Against

Tetracycline is used to treat many different infections including respiratory tract infections caused by Hemophilus influenza, Streptococcus pneumonia, or Mycoplasma pneumoniae. It also is used for urinary tract infections (UTIs), Rocky Mountain spotted fever, typhus, chancroid, cholera, brucellosis, anthrax, syphilis, lyme disease, acne and may be used concomitantly with other medications against Helicobacter pylori, the bacteria associated with stomach ulcers.

Antibiotic Resistance

Because tetracyclines have been around for so long, bacterial resistance is common, and the presence of tetracycline-resistant pathogens limits the use of this class of antibiotic.

Adverse Effects of Tetracyclines

Side effects may include nausea, diarrhea, and sensitivity to light. Tetracyclines also form complexes with calcium, which can stain the developing teeth of children and affect the strength and shape of bones.

Since tetracyclines are active against such a wide range of microbes, destruction of normal intestinal flora often occurs, resulting in increased secondary infections.


Comments

Post a Comment

Popular posts from this blog

article review on tocilizumab production

Tocilizumab (Actemra) is a humanized monoclonal antibody that targets the interleukin-6 (IL-6) receptor, which is involved in the inflammatory response. It is used to treat rheumatoid arthritis, systemic juvenile idiopathic arthritis and other inflammatory conditions. It is produced using recombinant DNA technology in Chinese hamster ovary (CHO) cells. One research article "Development of an efficient and scalable fed-batch culture process for the production of tocilizumab in Chinese hamster ovary cells" by Li et al. (2019) aimed to optimize the production of tocilizumab using a fed-batch cultivation system in CHO cells. The study aimed to improve the yield and quality of the protein, and to develop a process that can be easily scaled up for industrial production. The results of the study showed that the yield of tocilizumab was significantly improved by optimizing the culture conditions, such as the temperature, pH, and dissolved oxygen, as well as by using a specific
Read more

MOA OF AMINOGLYCOSIDE ANTIBIOTICS

Image
MOA                  of   Aminoglycoside             Antibiotics Aminoglycosides exert their bactericidal effect by inhibiting protein synthesis in bacteria and compromising the structure of the bacterial cell wall . Aminoglycoside Antibiotics Aminoglycoside antibiotics are used to treat serious infections caused by gram-negative bacteria . Some commonly used aminoglycosides include: amikacin (Amikin®); apramycin; capreomycin; gentamicin (Garamycin®); kanamycin (Kantrex®); neomycin (Mycifradin®); netilmicin (Netromycin®); paromomycin (Humatin®); streptomycin; tobramycin (TOBI Solution®, TobraDex®, Nebcin®) Mode of Action Although aminoglycosides stop bacteria from making proteins, it is uncertain whether this is the action that results in bacterial cell death.     Disruption of Protein Synthesis A minoglyco s i d e s b i n d to the b a c t er i al 3 0 S r i b o s o mal s ubunit. R i b o s om e s are the p ro t e i n
Read more

article review on adalimumab production

Adalimumab is a recombinant human monoclonal antibody that is used to treat a variety of inflammatory diseases, such as rheumatoid arthritis, psoriasis, and Crohn's disease. It is produced using recombinant DNA technology in Chinese hamster ovary (CHO) cells. A research article "Development of a high-titer, high-density fed-batch process for the production of adalimumab in CHO cells" by Chen et al. (2018) aimed to improve the production of adalimumab by developing a high-titer and high-density fed-batch process. The study used a CHO cell line that had been modified to express the adalimumab gene. The cells were grown in a culture medium containing glucose, amino acids, and a proprietary feed supplement, and the culture conditions were optimized to achieve high yields of the protein. The results of the study showed that a high yield of adalimumab (over 2g/L) was achieved using the fed-batch cultivation system. The study also found that the specific productivity of th
Read more